Stock comparison
AbbVie Inc. is 534.3x more valuable than Savara Inc by market capitalization ($510.74 B vs $955.99 M). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 534.3x more valuable than Savara Inc by market capitalization ($510.74 B vs $955.99 M).
Market value leader
ABBV
AbbVie Inc. is 534.3x more valuable than Savara Inc by market capitalization ($510.74 B vs $955.99 M).
Revenue leader
ABBV
SVRA: $257.00K vs ABBV: $61.16B.
Profit leader
ABBV
SVRA: -$118.84M vs ABBV: $4.23B.
Margin leader
ABBV
SVRA: -46240.1% vs ABBV: 6.9% net margin.
| Metric | SVRA | ABBV |
|---|---|---|
| Market cap | $955.99 M | $510.74 B |
| US-listed rank | #2553 | #21 |
| Revenue (latest FY) | $257.00K | $61.16B |
| Net income (latest FY) | -$118.84M | $4.23B |
| Net margin | -46240.1% | 6.9% |
| P/E (trailing FY) | - | 120.9x |
| SEC filings | 1,329 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 534.3x more valuable than Savara Inc by market capitalization ($510.74 B vs $955.99 M).
Full pages: Savara Inc and AbbVie Inc., or browse the full rankings.